Clinical Trials Directory

Trials / Completed

CompletedNCT00989768

Field of Effects of Two Commercial Preparations of Botulinum Toxin Type A

Field Effects of Two Commercial Preparations of Botulinum Toxin Type a Administered to the Frontalis Muscles

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
29 (actual)
Sponsor
Hexsel Dermatology Clinic · Academic / Other
Sex
Female
Age
18 Years – 60 Years
Healthy volunteers
Accepted

Summary

The objective of this study is to compare the field of effects of the botulinum toxins (Dysport® and Botox®) using two equivalence-ratios and to gather supportive information, such as more detailed data on the effectiveness in reduction of wrinkles and duration of action on the upper part of the face of both products, trough scales and photographs evaluations.

Detailed description

This was a monocentric, prospective, randomized and double-blind study. Twenty nine female patients, presenting with moderate to severe forehead wrinkles, with sweating ability who had never undergone previous BoNT-A injections were enrolled. Subjects have received botulinum toxin type-A injections in two forehead sites, Botox 2U and Dysport 5U, both reconstituted in the same volume of 0.02 mL per point. Baseline, twenty-eight and 112 days later, clinical and photographic assessments, Minor´s test, and electromyographic (EMG) evaluations were performed.

Conditions

Interventions

TypeNameDescription
DRUGBotulinum Toxin Type A (Dysport®)Botulinum toxin A (Dysport®)will be administered according to an equivalence ratio of 2,5:1. Both reconstituted in the same volume per point, injected in the forehead determined site. -Dysport®: 5 units will be injected in the left or right forehead side.
DRUGBotulinum Toxin Type A/Botox®2 units will be injected in the left or right forehead side.(opposite side of dysport injection)
DRUGBotulinum Toxin Type A/Dysport®Botulinum toxin A (Dysport®)will be administered according to an equivalence ratio of 2:1. Both reconstituted in the same volume per point, injected in the forehead determined site. -Dysport®: 4 units will be injected in the left or right forehead side, 2:1 ratio Dysport/Botox.

Timeline

Start date
2005-05-01
Primary completion
2007-11-01
Completion
2007-12-01
First posted
2009-10-06
Last updated
2010-06-02
Results posted
2010-04-27

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT00989768. Inclusion in this directory is not an endorsement.